NKMAX Yönetim

Yönetim kriter kontrolleri 0/4

Şu anda CEO hakkında yeterli bilgiye sahip değiliz.

Anahtar bilgiler

Sangwoo Park

İcra Kurulu Başkanı

n/a

Toplam tazminat

CEO maaş yüzdesi	n/a
CEO görev süresi	no data
CEO sahipliği	0.006%
Yönetim ortalama görev süresi	Veri yok
Yönetim Kurulu ortalama görev süresi	Veri yok

Son yönetim güncellemeleri

Recent updates

Introducing NKMAX (KOSDAQ:182400), A Stock That Climbed 96% In The Last Year

Feb 10

CEO

Sangwoo Park (54 yo)

no data

Görev süresi

Mr. Sangwoo Park was Executive Chairman of the Board at NKGen Biotech, Inc. since September 2023 until March 14, 2024. Mr. Park is Founder and was Executive Chairman of Legacy NKGen from May 2019 to Septem...

NKMAX Yönetim

Yönetim kriter kontrolleri 0/4

Anahtar bilgiler

Son yönetim güncellemeleri

No independent directors

No independent directors

Recent updates

New major risk - Share price stability

NKMAX CO., Ltd. announced that it has received KRW 7.5 billion in funding

NKMAX CO., Ltd. announced that it has received KRW 8.5 billion in funding

New minor risk - Shareholder dilution

Full year 2022 earnings released: ₩1,359 loss per share (vs ₩1,420 loss in FY 2021)

No independent directors

No independent directors

NKMAX CO., Ltd. announced that it has received KRW 21.40019775 billion in funding

NKMAX CO., Ltd. announced that it expects to receive KRW 7.00019775 billion in funding

Introducing NKMAX (KOSDAQ:182400), A Stock That Climbed 96% In The Last Year

New 90-day high: ₩20,900

New 90-day high: ₩18,000

NKMAX CO., Ltd. announced that it has received KRW 29.9999702 billion in funding from a group of investors

New 90-day low: ₩12,900

New 90-day low: ₩12,950

New 90-day high - ₩15,800

CEO

Görev süresi